An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Northera

Chemical Namedroxidopa
Dosage FormCapsules (oral; 100mg, 200mg, 300mg)
Drug ClassVasopressors
SystemCardiovascular
CompanyChelsea Therapeutics
Approval Year2014

Indication

  • For the treatment of orthostatic dizziness and light-headedness in adult patients with symptomatic neurogenic orthostatic hypotension caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropath.
Last updated on 4/20/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Northera (droxidopa) Prescribing Information2014Chelsea Therapeutics, Inc., Charlotte, NC
Document TitleYearSource
Droxidopa for orthostatic hypotension: a systematic review and meta-analysis. 2016Journal of Hypertension